企業プロフィール

Kenvue 株価・ニュース・カタリスト

ティッカー:
KVUE
取引所:
NYSE
セクター:
Biopharma
所在地:
United States

株価パフォーマンス

18.79 USD (-2.14%)

終値

最終更新: 2026年8月17日

33.3B USD

時価総額

株価変動の要因

As of Aug 17, 2026, KVUE closed down 2.14% at $18.79. No new same-company headline was identified in the current news window.

企業概要

事業概要

Kenvue is a consumer health company focused on over-the-counter and personal care brands rather than pharmaceuticals or biotech. Its portfolio is anchored by familiar household products across skin health, oral care, and self-care.

所在地とセクター分類

Headquartered in the United States and listed on NYSE, Kenvue has a global consumer-health footprint. It is a consumer products company, not a biotech or medtech business.

ビジネスモデルの特徴

The business depends on brand strength, retail distribution, pricing power, and steady consumer demand. Investors watch revenue growth, margin discipline, and portfolio management rather than clinical or regulatory catalysts.

バイオ業界での位置付け

Kenvue sits outside biotechnology and even outside most healthcare innovation categories. It belongs in consumer health, where brand execution and demand stability matter more than research-driven catalysts.

今後のカタリスト

  • Kenvue’s near-term catalysts are consumer-health earnings, margin stabilization, and whether the company can keep proving the post-spin story is getting cleaner. This matters because it helps show whether the company can turn its current footprint into a cleaner earnings profile. Better execution here can matter even before a new product or trial headline lands.

最近のニュース

    類似銘柄

    事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。